147 related articles for article (PubMed ID: 17092759)
1. Human papillomavirus E2 protein associates with nuclear receptors to stimulate nuclear receptor- and E2-dependent transcriptional activations in human cervical carcinoma cells.
Wu MH; Chan JY; Liu PY; Liu ST; Huang SM
Int J Biochem Cell Biol; 2007; 39(2):413-25. PubMed ID: 17092759
[TBL] [Abstract][Full Text] [Related]
2. Physical and functional interactions of human papillomavirus E2 protein with nuclear receptor coactivators.
Wu MH; Huang CJ; Liu ST; Liu PY; Ho CL; Huang SM
Biochem Biophys Res Commun; 2007 May; 356(3):523-8. PubMed ID: 17376404
[TBL] [Abstract][Full Text] [Related]
3. The HPV16 E2 transcriptional regulator mode of action depends on the physical state of the viral genome.
Schmidt MT; Olejnik AK; Goździcka-Józefiak A
Acta Biochim Pol; 2005; 52(4):823-32. PubMed ID: 16273126
[TBL] [Abstract][Full Text] [Related]
4. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
Subbaramaiah K; Dannenberg AJ
Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
[TBL] [Abstract][Full Text] [Related]
6. The regulation of cell proliferation by the papillomavirus early proteins.
Hamid NA; Brown C; Gaston K
Cell Mol Life Sci; 2009 May; 66(10):1700-17. PubMed ID: 19183849
[TBL] [Abstract][Full Text] [Related]
7. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2.
Bhattacharjee B; Sengupta S
Virology; 2006 Oct; 354(2):280-5. PubMed ID: 16905170
[TBL] [Abstract][Full Text] [Related]
8. A new E6/P63 pathway, together with a strong E7/E2F mitotic pathway, modulates the transcriptome in cervical cancer cells.
Teissier S; Ben Khalifa Y; Mori M; Pautier P; Desaintes C; Thierry F
J Virol; 2007 Sep; 81(17):9368-76. PubMed ID: 17582001
[TBL] [Abstract][Full Text] [Related]
9. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
10. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
11. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
[TBL] [Abstract][Full Text] [Related]
12. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
13. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes.
Medina-Martínez O; Vallejo V; Guido MC; García-Carrancá A
Mol Carcinog; 1997 Jun; 19(2):83-90. PubMed ID: 9210955
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
Koivusalo R; Krausz E; Helenius H; Hietanen S
Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516
[TBL] [Abstract][Full Text] [Related]
15. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.
Gammoh N; Grm HS; Massimi P; Banks L
J Virol; 2006 Feb; 80(4):1787-97. PubMed ID: 16439535
[TBL] [Abstract][Full Text] [Related]
17. Expression of S100P gene in cervical carcinoma cells is independent of E7 human papillomavirus oncogene.
Jakubícková L; Baráthová M; Pastoreková S; Pastorek J; Gibadulinová A
Acta Virol; 2005; 49(2):133-7. PubMed ID: 16047742
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.
Donalisio M; Cornaglia M; Landolfo S; Lembo D
Virus Res; 2008 Mar; 132(1-2):253-6. PubMed ID: 18206261
[TBL] [Abstract][Full Text] [Related]
19. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.
Desaintes C; Goyat S; Garbay S; Yaniv M; Thierry F
Oncogene; 1999 Aug; 18(32):4538-45. PubMed ID: 10467398
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin.
Mistry N; Simonsson M; Evander M
Virol J; 2007 Mar; 4():27. PubMed ID: 17352804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
